Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$525.19 - $619.13 $8,403 - $9,906
-16 Reduced 1.13%
1,401 $816,000
Q3 2023

Oct 19, 2023

SELL
$434.7 - $599.3 $309,941 - $427,300
-713 Reduced 33.47%
1,417 $761,000
Q2 2023

Jul 26, 2023

BUY
$350.74 - $468.98 $747,076 - $998,927
2,130 New
2,130 $998,000
Q4 2021

Jan 26, 2022

BUY
$224.85 - $279.04 $196,518 - $243,880
874 Added 219.05%
1,273 $353,000
Q2 2021

Jul 21, 2021

BUY
$180.55 - $233.54 $722 - $934
4 Added 1.01%
399 $92,000
Q4 2020

Jan 27, 2021

BUY
$130.46 - $172.63 $51,531 - $68,188
395 New
395 $66,000
Q3 2020

Oct 26, 2020

SELL
$146.22 - $169.13 $94,165 - $108,919
-644 Closed
0 $0
Q2 2020

Aug 05, 2020

SELL
$136.42 - $164.18 $168,342 - $202,598
-1,234 Reduced 65.71%
644 $105,000
Q4 2019

Jan 14, 2020

BUY
$106.92 - $132.43 $86,819 - $107,533
812 Added 76.17%
1,878 $247,000
Q3 2019

Oct 24, 2019

BUY
$106.79 - $116.16 $113,838 - $123,826
1,066 New
1,066 $120,000
Q2 2019

Aug 02, 2019

SELL
$110.79 - $129.32 $34,898 - $40,735
-315 Closed
0 $0
Q1 2019

Apr 29, 2019

SELL
$111.31 - $131.02 $728,969 - $858,049
-6,549 Reduced 95.41%
315 $41,000
Q4 2018

Jan 16, 2019

BUY
$105.9 - $118.64 $698,304 - $782,312
6,594 Added 2442.22%
6,864 $784,000
Q2 2018

Jul 09, 2018

SELL
$75.7 - $86.88 $939,134 - $1.08 Million
-12,406 Reduced 97.87%
270 $23,000
Q1 2018

May 01, 2018

BUY
$74.21 - $87.6 $717,165 - $846,566
9,664 Added 320.85%
12,676 $976,000
Q4 2017

Feb 06, 2018

BUY
$81.94 - $87.89 $246,803 - $264,724
3,012
3,012 $256,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Center Star Asset Management, LLC Portfolio

Follow Center Star Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center Star Asset Management, LLC with notifications on news.